Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: Shanghai Henlius Biotech
Condition: Carcinoma, Hepatocellular
NCT06742892
A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.